<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 286 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page285.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=286">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 286 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 286</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=286"><img src="../thumb/286.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Anti-Microbials - 18.9 / 18.10                                                 2020-04 / 249
                                                                                      +
       Contraindications: MAOI’s, safety when admin. for long.than   Drug interactions: In view of poss. reduc.ser.K  digit.glycos.or musc.
       28 days not est.              18.10   Anti-fungal agents   relax.effs.poss.incr., corticoster./ corticotroph.K  loss poss.incr., other
                                                                                      +
       Side effects: Thrombocytopen., bld.dyscras., hypo-/hypertens.,   nephrotox.medic.may enhanc.nephrotoxic.potent.
       tinnit., blurr.vis., headache, monilias./fung. infect., chills, fatig.,   ERAXIS (MDR Listing)
       phlebit./ thrombophlebit., GI disturbs., pancreatit., stomatit.,   MYCAMINE (MDR Listing)  ARICON, (Teva) Actavis [P/S]
       tong.discolour., abnorm. LFT/lab.tests, metall. taste, incr.non-  ADCO-SPOROZOLE, AI Pharm. [P/S]  Fluconazole.
       fast.gluc., dizzin., paraesthes., CNS effs., vulvovag.disord., vag-  Indications: Adults & childr: Cryptococ. meningit. & maint.ther.to
       init., polyur., skin reacts.  Itraconazole.                prev.cryptococ.dis. relapse in AIDS pts, coccidioidomycos., system.
                                     Indications: Persist.vulvovag.candidias.& dermatophytos.not re-
       Warnings and special precautions: Pseudomembr. colit., super-  candidias., mucos.candidias.incl.oropharyng.& oesophag. candidias./
       infect., sev.ren.insuffic., not admin.after haemodialys., avoid ingest.  spond.to convent.ther., fung. keratit., onychomycos.caus.by yeasts   candidur./chron.mucocut. candidias., chron.oral atroph.candidias.
                                     &/ dermatophytes, syst.asperigillos./blastomycos./ candidias./coc-
       large amounts of food with high tyramine cont., consid. platel.count   cidioidomycos./histoplasmos./ paracoccidioidomycos.& sporotrichos.  if dent. hygiene./topic.treatm.insuffic., ac/recurr.vag. candidiasis,
       monit.in pts.with pre-exist. thrombocytopen./ receiv.concom.meds.  (S4) CAPS, 37/20.2.2/0559  candidial balanitis, dermatomycos. incl.tinea cruris, tinea corporis,
       decr.platel. count or funct./receiv.ther.for long.than 28 days, no stud-  705371-001: 100 mg, 4, R140,51  tinea pedis, tinea unguium (onychomycosis) & derm.candida infects.
       ies in uncontr.hypertens./ phaeochromocytoma/ carcinoid syndr./  705371-002: 100 mg, 14, R491,80  Adults: Prophylax. of oropharyng./oesophag. candidias. relapse in
       untreat. hyperthyroid./tumour-relat.condit./decubit.ulc. treatm.,   705371-003: 100 mg, 28, R983,59  HIV pts at risk, prophylax.to reduc.recurr.incid of vag.candidias.(ie 4
       lact.intol., safety in pregn.& lactat.not est. inappropr.antibiot.use,   Dosage: Admin.with food.  or more/ yr.), fung.infect.prophylax.in pts.with malign. predispos.to
       compounds e.g.dopamine/ adrenal.to be titr.achiev.desir.repons.  Vulvovag.candidias: 200 mg 2xdly. x1day.  such infects.due to chemo & radiother.
       Drug interactions: Potent.for interact.with serotonerg./sympatho-  Tinea corporis/cruris: 100 mg dly.x15 days or 200 mg dly.x7 days.  (S4) CAPS, 45/20.2.2/0904, 0906
       mimet./adrenerg.agents, mild revers.enhancem.of press.respons.  Tinea pedis /manus: 100 mg dly.x30 days or 200 mg 2xdly.x7 days.  723426-001, 50 mg, 14, R111,18
       induc.by pseudoephedr./ phenylpropanolamine HCl.  Fung.keratit: 200 mg dly.x21 days.  723427-001: 200 mg, 28, R386,71
                                                                  Dosage: Cont.ther.requir.multipl.dos.treatm.until lab. tests & clinic.
       ZYVOXID, Pfizer [P/S] &       Onychomycos: Continuous treatm: 200 mg dly. x3 mnths. Pulse   paramet.indic.act.infect.subsid. Dos. & durat.bas.on site of infect.&
       Linezolid                     treatm: 200 mg 2xdly.x 1 wk.(=1 pulse treatm.). Pulse treatm.are   indiv.respons. to ther., maint.ther.usually reqd.in AIDS pts.with cryp-
       Indications: Vancomycin-resist. Enterococcus faecium infects.  separat.by 21 day (3 wk.) drug-free interv. Fingernail infects: 2 pulse   tococc. meningit/recurr.oropharyng.candidias.
       incl.bacteraem., nosocomial/ commun. acquir.pneumon.caus.by   treatm. Toe nail infects.: 3 pulse treatm.  Cryptococ.meningit: Adults: Init.400 mg on 1st day, then 200-400
       Staphylococcus aureus (methicilllin-suscept.& -resist. strains) or   Aspergillos: 200 mg dly. x2-5 mnths. Incr.dos.to 200 mg 2xdly for   mg dly.depend.on clinic. respons. Durat.usual.6-8 wks. In life threat.
       Streptococcus pneumoniae (incl.multi-drug resist.S pneumoniae   invas./ disseminat.dis.  infects. dos can be incr.to 800 mg dly.
       strains) incl.bacteraem., complic.skin & skin struct. infects.caus.  Candidias: 100-200 mg dly.x3 wks.-7 mnths. Incr.dos.to 200 mg   Relapse prevent.in AIDS pts: Admin.dly.dos.of 200 mg aft.full
       by Staphylococcus aureus (methicilllin-suscept.& -resist.strains)/   2xdly for invas./ disseminat.dis.  course of prim.ther.
       Streptococcus pyogenes or Streptococcus agalactiae, uncomplic.  Histoplasmos.(excl.meningeal): 200 mg dly.to 200 mg 2xdly. OR   Coccidioidomycosis: 200 - 400 mg for 11-24 mnths./ long.depend.
       skin & skin struct. infects. caus. by Staphylococcus aureus (me-  400 mg dly.x8 mnths.  on pt. 800 mg dly may be consid. in some pts.esp.for meningeal dis.
       thicilllin-suscept. & -resist.strains) & Streptococcus pyogenes.   Sporotrichos: 100 mg dly.x 3mnths.  Invas.candidias: Adults: 1st day 800 mg, then 400 mg dly. Recomm.
       (S4) TABS, [P/S] 35/20.1.1/0310  Paracoccidioidomycos: 100 mg dly.x6 mnths.  durat.of ther.is for 2 wks aft. 1  neg. bld.culture result & resolut.of
                                                                               st
       700464-007: 600 mg, 10, R5 988,10  Chromomycos: 100-200 mg dly.x6 mnths.  signs & sympts. attributab.to candidemia.
       (S4) SOL FOR INFUS, [P/S] 35/20.1.1/0312, 0313  Blastomycos: 100 mg dly.to 200 mg 2xdly.OR 400 mg dly.x 6 mnths.  Oropharyngeal candidias: Adults: 200-400 mg on 1st day fol-
       708873-002: 200 mg/100 ml, 10 units, R2 158,10  Contraindications: Pregn., concom.terfenadine/ astemizole/   low.by 100-200 mg once dly. Treat for 7-21 days until oropharyng.
       898507-008:, 600 mg/300 ml, 10 units, R6 474,29  cisapride/quinidine/pimozide & CYP3A4 metabol.HMG-COA re-  candid.in remiss., Relapse prevent.in HIV pts: 100-200 mg dly.
       (S4) GRANS FOR SUSP, [P/S] 35/20.1.1/0311  duct.inhibit.such as simvastin & lovastatin/oral triazolam & mida-  (or 200 mg 3x/wk.)
       700466-003: 20 mg/ml, 150 ml, R5 229,32  zolam, hypersens.to other azole antifung. agents., not stud. in childr.  Oesophag.candidias:  Adults: 200-400 mg on 1st day follow.
       Dosage: Any dos.form to be used as init.ther. Switch to either   und.12 yrs & elderly, onychomycos. treatm. when evid.of ventricul.  by 100-200 mg once dly. Treat for 14-30 days until oesophag.can-
       oral prep.when clinic.indic.if ther. start.with parent. formulat. In-  dysfunct.pres., lactat.  did.in remiss.
       fus. sol.over 30-120 mins.    Side effects: Idiosyncrat.hepatit.with report. fatalit., cholestat. jaund.,   Relapse prevent.in HIV pts: 100-200 mg dly.(or 200 mg 3x/wk.)
       Adults & adolesc.12 yrs & old:  GI disturbs., headache, dizzin., skin reacts.incl. Stev.-Johns.syndr.,   Candiduria:  Adults: 200-400 mg dly. Treat for 7-21 days depend.
       Commun.acquir.& nosocomial pneumon.incl. concurr.bac-  alopec. with prolong.treatm., oed., hypokalaem., adren. suppress./   on pt.respon.
       teraem: 600 mg IV or orally 12 hrly x10-14 days.  menstr.disords.& periph.neuropathy with high dos., negat.inotrop.eff.,  Chron.atroph.candidias:  Adults: 50 mg dly.for 14 days.
       Skin & soft tiss.infect.incl.concurr. bacteraem: 400-600 mg   Special precautions: Teratogenic.in lab.anim., adeq. contracept.dur.  Chron.mucocutan.candidias:  Adults: 50-100 mg dly.for up
       orally/600 mg IV 12 hrly. depend. on clinic.sev.x10-14 days.  ther.in women of child-bear. potent. & one menstr.cycle aft.stopp.ther.,   to 28 days.
       Enterococc.infects incl.vancomycin-resist. infects,& those   avoid in liv. dis., monit.liv.funct.in treatm.exceed.1 mnth., pts. to report   Vag.candidiasis: Adults: 150 mg as sngl.dos.
       with concurr.bacteraem: 600 mg IV/orally 12 hrly x14-28 days.  S&S of liv.dysfunct., discont.if neuropathy develops, CHF/hist.thereof,   Recurr.vag.candidias: Adults: 150 mg on days 1,4 & 7 of treatm.,
       Paediatric. Birth – 11 yrs: Pre-term neonates &lt;7 days of age   absorpt. decr. in hypochlorhydr.theref.admin.with acidic drink e.g.cola   follow.by maint.dos.of 150 mg 1x/wk for 6 mnths.
       (gestat.age &lt;34 wks.) have low. system. clear.& larg.AUC values   beverage to improv.absorpt., admin. antacids 2 hrs.aft., ren.impairm.  Candida balanitis: Adults: 150 mg as sngl.dos.
       than full-term neonates & old.infts. By 7 days of age they are simi-  Drug interactions: Terfenadine conc.incr.lead.to ser. CV advers.  Dermatomycos.eg.tinea pedis, corporis, cruris and candida
       lar to full term/old.infts.   effs., enzyme induc.agents eg. rifampicin/ carbamazepine/pheny-  infects: Adults: 150 mg once wkly. (or 50 mg once dly) x2-4 wks.
       Commun.acquir.& nosocomial pneumon.incl. concurr.bac-  toin & phenobarbit. decr.plasma conc., absorpt.imp.by agents decr.  but up to 6 wks. for tinea pedis.
       teraem: 10 mg/kg IV or orally 8 hrly. x10-14 days.  stomach acid., plasma conc.of meds. metabol. by CYP3A4 enzyme   Tinea versicolor: Adults: 300-400 mg once wkly. x 1-3 wks.(or
       Skin & soft tiss.infect.incl.concurr. bacteraem: 10 mg/kg IV   incr., effs.of digox.& vincrist. incr., OC effic.poss.reduc., addit.negat.   50 mg once dly.for 2-4 wks)
       or orally 8 hrly. x10-14 days.  inotrop. effs.with Ca chann.block., metabol.of Ca chan. block.inhibit.  Tinea unguium: Adults: 150 mg once wkly.x3-12 mnths until nail
       Enterococc.infects incl.vancomycin-resist. infects,& those   AMBISOME, Key Oncologics [P/S]  completely replac.
       with concurr.bacteraem: 10 mg/kg IV or orally 8 hrly.x14-28 days.  Amphotericin-B.encaps.in liposomes.  Candidias.prophylax in pts. with prolong. neutropen.: Adults:
       Contraindications: MAOI’s, safety in pregn.& lactat. not est.,   Indications: Presum.fung.infect.in febrile neutropaen.adults & childr.  200 mg- 400 mg. Commenc. ther.sev.days bef.anticipat.neutropen &
       safety & effic.of ther.long.than 28 days not est., no studies with   unrespons.to anti-bact.treatm., sev. system.&/deep mycoses in adults   contin.x7 days aft. neutrophil count rises above 1000 cells per mm   3
       uncontr.hypertens./ carcinoid syndr./phaeochromocytoma/untreat.   and childr.when toxic.(partic.nephrotox.) preclud. use of convent.sys-  Paed:
       hyperthyroid., introd. addit. into IV sol.  tem.amphotericin B/pts.resist.to convent.amphotericin B, prim.ther. of   Childr.to11 yrs: Max.dly dos.of 400 mg should not be exceed.
                                                                                 st
       Side effects: Headache, pseudomembr.colit., metall.taste,   viscer.leishmanias.in immunocompet.adults & childr. & immuncom-  Mucos.candidias: 6 mg/kg on 1  day follow. by 3 mg/kg once dly.
       abnorm.LFT, CNS effs., vag. monilias., fung.infect., taste alter.,   prom.adults, cryptococc. meningit.in HIV-infect.pts.  Invas,candidias & cryptococc.meningit: 6-12 mg/kg/day de-
       chills, fatig., fev., loc. reacts., angioed., anaphylax., bld.dys-  (S4) IV INFUS, 36/20.2.2/0453  pend. on sev.of infect.
       cras., hyperglycaem., dizzin., tinnit., periph./optic. neuropathy,   700235-001: 50 mg, 1 vial, R2 657,63  Maint.ther. to prev. relapse of cryptococc. meningit. in childr.
       convuls., vis./GI disturbs., hyper/-hypotens., pancreatit., sto-  Dosage: Admin.IV infus.over 30-60 mins. Recomm. conc.is 0,20-  with high risk of
       matit., tong. discolourat. /disord., skin reacts.incl.Stev.John.  2,00 mg/ml. Reconstit.with ster. water for inj.only as per manufact.   recurr: 6 mg/kg/day depend.on severity.
       syndr., urogenit. disords.    lit. Do not mix.with other drugs/electrol.. Flush.exist.IV line with 5%   Candida propylax.in immunocompromis.pts: 3-12 mg/kg dly.
       Warnings and special precautions: Consid. alternat. bef.init.  dextr.inj.bef.admin.& if not feasible admin. through separate line.  depend.on extent & durat.of induc.neutropen.
       ther.in outpt.setting, determ. suscept. bef.init.ther., monit.potent.BP   Adults:   Adolesc.12-17 yrs: Dos.depend.on weight and pubert.developm.
       incr.in uncontr. hypertens./ phaeochromocyt./ thyrotoxicos. &/pts.  Empiric.ther: 3 mg/kg/day  Adult dos.of 100/200 ad 400 mg corresponds to 3/6 and 12  mg/kg
       tak.direct./indirect.act. sympathomimets./vasopress.agents/dopa-  System.fung.infects: 3 mg – 5 mg/kg/day.  to obt.compar.syst.expos.
       minerg., monit. for seroton.syndr.S&S in carcin. syndr.pts. &/pts.tak-  Cryptococc.meningit.in HIV infect.pts: 6 mg/ kg/day  Safety & effic.for genit.candidias.indicat.in paed. not est. If treatm.
       ing seroton.re-uptake inhibits./TCA’s/ seroton. 5-HT1 recept.agon./  Visceral Leishmaniasis: Immuno-competent pts: 3 mg/kg/  for genit.candidias.imperative in adolescs (12 – 17 yrs) the dos.
       meperidine/ buspirone, C difficile assoc.diarrh.somet.life-threat.,   day on days 1 - 5, day 14 & day 21. Immuno-compromised pts:   same as adult dos.
       blood monit.in pts.with incr.bleed. risk/pre-exist.myelosuppress./  4 mg/kg/day on days 1 - 5, day 10, day 17, day 24, day 31& day 38.  Contraindications: Known azole antifung. hypersens., co-admin.
       concom.meds.decr.Hb lev.or platel. count or funct./receiv.Zyvoxid   Childr: Calculat.dos.on same per/kg body weight basis as for adults.  meds.known to prolong QT interv.& metabol. via CYP3A4 incl.cisap-
       for more than 2 wks., poss.lact.acidos., seiz.hist./risk fact., not ap-  Contra-indications: Safety in pregn., lactat. & infts. &lt; 1 mnth.  ride/ astemizole/ erythromycin/quinidine/pimozide, concom. terfena-
       prov. for cathet.-relat.bloodstream infects., superinfect., cons.be-  not est.  dine with multiple fluconazole dos. &gt;400 mg/day, multiple dos.ther.in
       nef.vs risk in sev.ren./hepat. insuffic., not stud.in treat.decubit.ulc.,   Side-effects: Fev., chills, rigors, back pain, chest tightn/pain, dyspn.,   ren.impairm., concom.halofantrine, pregn. & breastfeed.
       those at high risk for life threat.syst.infects., cons.benef.vs. risk in   bronchosp., vasodilat., flush., tachycard., hypotens., hypokalaem., hy-  Side effects: GI disturbs., rash, headache, hepat. ren. & haema-
       case periph./opt.neuropathy occurs, ophthalm. eval.recomm.if vis.  pomagnesaem., hypocalcaem., hyperglycaem., hyponatraem., GI dis-  tolog.funct.disturbs.partic.in pts.with ser. underly.dis., CNS/psych.
       impairm.sympt., monit. vis.funct.if ther.giv.for extend.per./beyond   turbs., headache, rash, convuls., anaphylact. react., angioed., throm-  effs., alopec., bld. dyscras., allerg.reacts.incl.anaphylax./angioed.,
       max. recomm.durat., tyramine restrict.diet, discont. either/both   bocytopaen., anaem., abnorm.LFT, hyperbilirubinaem.  hypertriglyceridaem., hypercholesterolaem., hypokalaem., polyruia,
       agents in case of seroton.syndr.with concom.serotonerg.agents.   Special precautions: Outweigh benef.-risk in pts.who have   thirst, intermenst.bleed., leukorrh., menorrhag., fem.sex.dysfunct.,
       Drug interactions: Mild revers.enhancem.of press. respons.in-  shown hypersens. when infect.life-threaten.& only amenable to   flush., malaise, rigors, fatig., abnorm.vis., taste pervers.
       duc.by pseudoephedr.& phenylpropanolamine HCl, potent. inter-  Ambisome, advers. reacts. have resolv.on discont.& reacts.may not   Warnings and special precautions: Monit.pts. develop. abnorm.
       act.with sympathomimet./adrenerg.agents, seroton.syndr. with   occur with every subseq.dos./when admin.at slow. infus.rates of   liv.funct. for more serious hepat. injur., careful.monit.pts.receiv.con-
       concom.serotonerg.agents incl.antidepress., decr.AUC & Cmax with   2 hrs., consid.precaut.meas.to reduc. advers. reacts.e.g. diphenhy-  com.terfenadine at fluconazole dos.&lt;400 mg/day, monit.pts.with
       rifampicin., physic.incompat. with amphotericin B/chlorpromazine   dram./paracet./ pethidine/hydrocortis.may successful.prev./treat   rash. closely & discont.ther.if bullous les./ erythema multiforme
       HCl/ diazepam/ pentamine isethionate/ phenytoin sod./ erythro-  them, prolong.ther., monit.ren./liv./haematopoiet. funct.& K / Mg   develops, AIDS pts.more suscept. to cutan.reacts., IV infus.in pts.
       mycin lactobionate/ trimethoprim-sulfamethoxazole, chemic.in-  lev., diabet.as 900 mg sucr./vial pres, for dos.&gt; 5 mg/kg/day IV infus.  requir. Na / fluid restrict., imp.ren.funct., bleed.events report. with
                                                                       +
       compat.with ceftriaxone sod.  over 2 hr. period is recomm., separ.leukocyt.tranfus.by as long a per.  concom.warfar., monit.prothromb. time with concom.warfarin,. incr.
       See also MDR page 677.        as poss.& monit.pulm.funct.  risk of theophyll. toxic., uveit.in pts.receiv.rifabutin, nephrotox. report.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page285.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page281.html">281</a>&nbsp;&nbsp;&nbsp;<a href="page282.html">282</a>&nbsp;&nbsp;&nbsp;<a href="page283.html">283</a>&nbsp;&nbsp;&nbsp;<a href="page284.html">284</a>&nbsp;&nbsp;&nbsp;<a href="page285.html">285</a>&nbsp;&nbsp;&nbsp;<a href="page286.html">286</a>&nbsp;&nbsp;&nbsp;<a href="page287.html">287</a>&nbsp;&nbsp;&nbsp;<a href="page288.html">288</a>&nbsp;&nbsp;&nbsp;<a href="page289.html">289</a>&nbsp;&nbsp;&nbsp;<a href="page290.html">290</a>&nbsp;&nbsp;&nbsp;<a href="page291.html">291</a>
             </td>
             <td width="35%"><a href="page287.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page287.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
